Glaxosmithkline receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GSK plc DRC (GSK)
Track today's live GSK plc DRC (GSK) share price, performance and key data on this page with our current NYSE:GSK stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the GSK plc DRC share price on the NYSE exchange. Use the dropdown to switch exchange for the GSK share price, head to our technical summary section, which provides analysis on GSK plc DRC share price buy/sell indicators using real-time data (or discuss the GSK plc DRC (GSK) stock price today with other investors in the GSK plc DRC NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE:GSK share price (ISIN: US37733W2044) to enhance your trading decisions with our free investment tools and resources.
What Is the GSK plc DRC Share Price Today?
The GSK plc DRC share price today is 52.07.
What Is the Stock Symbol for GSK plc DRC
The stock symbol (or 'ticker') for GSK plc DRC is "GSK."
What Stock Exchange Does GSK plc DRC Trade On?
GSK plc DRC is listed and trades on the NYSE stock exchange.
Is GSK plc DRC a Good Stock to Buy?
Determining whether GSK plc DRC (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NYSE:GSK share price (ISIN: US37733W2044) to enhance your trading decisions with our free investment tools and resources.
What Is the GSK plc DRC Share Price Today?
The GSK plc DRC share price today is 52.07.
What Is the Stock Symbol for GSK plc DRC
The stock symbol (or 'ticker') for GSK plc DRC is "GSK."
What Stock Exchange Does GSK plc DRC Trade On?
GSK plc DRC is listed and trades on the NYSE stock exchange.
Is GSK plc DRC a Good Stock to Buy?
Determining whether GSK plc DRC (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
51.87
52.70
52 wk Range
36.75
61.70
GSK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
51.8752.70
52 wk Range
36.7561.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GSK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
58.08
Upside
+11.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
2 Buy
5 Hold
1 Sell
Ratings:
8 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 58.08
(+11.54% Upside)
GSK plc DRC Earnings Call Summary for Q2/2026
- GSK Q2 2026 EPS of $0.68 beat estimates by $0.21; revenue of $11.15B topped forecasts by $2.9B; shares rose 3.35% to $53.72 in premarket.
- Specialty medicines grew 14%, vaccines up 8%, offsetting 9% decline in general medicines; gross margin expanded 250 basis points on mix and efficiency.
- Raised full-year sales and operating profit guidance to upper half of range; EPS guidance lowered to lower half due to $160M Nuvalent interest costs.
- Launched 'Accelerate Growth' program targeting £1.9B annual cost savings by 2029; plans to reinvest in pipeline with 20+ Phase III trials starting in 2026.
- Reaffirmed 2031 target of £40B+ sales with specialty medicines exceeding 50%; net debt at £22B post-Nuvalent; dividend yield 3.44% with 35-year streak.
Last Updated: 28/07/2026, 17:36
Read Full TranscriptEarnings
Latest Release
28/07/2026
EPS / Forecast
0.68 / 0.47
Revenue / Forecast
11.15B / 8.25B
Compare GSK to Peers and Sector
Metrics to compare | GSK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGSKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.0x | 21.5x | −0.3x | |
PEG Ratio | 0.38 | 0.22 | 0.00 | |
Price/Book | 4.4x | 5.1x | 2.6x | |
Price / LTM Sales | 2.3x | 2.7x | 3.0x | |
Upside (Analyst Target) | 7.5% | 17.1% | 56.6% | |
Fair Value Upside | Unlock | 13.5% | 10.2% | Unlock |
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GSK plc DRC (NYSE: GSK) Share Price Today?
The GSK plc DRC stock price today is 52.07 USD.
What Stock Exchange Does GSK plc DRC (GSK) Trade On?
GSK plc DRC is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for GSK plc DRC?
The stock symbol (also called a 'ticker') for GSK plc DRC is "GSK."
Does GSK plc DRC Pay Dividends? What’s The Current GSK Dividend Yield?
Yes, GSK Pays Dividends to its Shareholders. The current GSK plc DRC dividend yield is 3.41%.
What Is the Current GSK plc DRC Market Capitalisation?
As of today, GSK plc DRC (NYSE: GSK) market cap is 104.00B USD.
What Is GSK plc DRC's (GSK) Earnings Per Share (TTM)?
The GSK plc DRC EPS is currently 1.18 (Trailing Twelve Months).
When Is the Next GSK plc DRC Earnings Date?
GSK plc DRC's next earnings report will be released on 28/10/2026.
Is GSK a Buy or Sell From a Technical Analyst Perspective?
Based on today's GSK plc DRC moving averages and other technical indicators, the daily buy/sell signal for GSK stock is Neutral.
How Many Times Has GSK plc DRC Stock Split?
GSK plc DRC has split 5 times. (See the GSK stock split history page for full effective split date and price information.)
How Many Employees Does GSK plc DRC Have?
GSK plc DRC has 66841 employees, based on their latest Companies House report.
What is the current trading status of GSK plc DRC (NYSE: GSK)?
As of 31/07/2026, GSK plc DRC (GSK) is trading at a share price of 52.07 USD, with a previous close of 53.22 USD. The stock has fluctuated within a day range of 51.87 USD to 52.70 USD, while its 52-week range spans from 36.75 USD to 61.70 USD.
What Is GSK plc DRC (GSK) Price Target According to Analysts?
The average 12-month price target for GSK plc DRC is 58.08 USD, with a high estimate of 70 USD and a low estimate of 47 USD. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +11.54% Upside potential.
What Is the GSK Premarket Price?
GSK's last pre-market stock price is 52.47 USD. The pre-market share volume is 156,580.00, and the stock has decreased by -0.75, or -1.41%.
What Is the GSK After Hours Price?
GSK's last after hours stock price is 52.11 USD, the stock has decreased by 0.04, or 0.08%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.